Fetal risk associated with rubella vaccine: an update.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 4001743)

Published in Rev Infect Dis on June 25, 1985

Authors

S W Bart, H C Stetler, S R Preblud, N M Williams, W A Orenstein, K J Bart, A R Hinman, K L Herrmann

Articles by these authors

Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43

Field evaluation of vaccine efficacy. Bull World Health Organ (1985) 4.95

Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77

Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med (2000) 3.65

Rational strategy for rubella vaccination. Lancet (1983) 3.61

Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev (1988) 3.51

Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med (1988) 3.49

AIDS and absolutism--the demand for perfection in prevention. N Engl J Med (1992) 3.03

Measles vaccine efficacy in children previously vaccinated at 12 months of age. Pediatrics (1978) 2.98

The opportunity and obligation to eliminate measles from the United States. JAMA (1979) 2.93

Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health (1985) 2.58

The immunization system in the United States - the role of school immunization laws. Vaccine (1999) 2.57

Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55

Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med (1989) 2.41

Diagnosis and etiology of nongonococcal urethritis. J Infect Dis (1978) 2.40

The sample household health interview survey. Am J Public Health (1982) 2.35

Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA (1987) 2.28

Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry (2010) 2.21

A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13

Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12

Developing the Guide to Community Preventive Services--overview and rationale. The Task Force on Community Preventive Services. Am J Prev Med (2000) 2.10

Continuing measles transmission in students despite school-based outbreak control program. Am J Epidemiol (1985) 2.09

Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev (1999) 2.09

Sensitivity and specificity of diagnostic tests for genital infection with herpesvirus hominis. Sex Transm Dis (1979) 2.09

Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07

Immune status of children one to four years of age as determined by history and antibody measurement. N Engl J Med (1973) 2.06

Use of health services. Am J Public Health (1982) 2.06

Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93

From the Center for Disease control: current status of measles in the United States, 1973--1977. J Infect Dis (1978) 1.91

Progress in measles elimination. JAMA (1982) 1.87

Appropriate age for measles vaccination in the United States. Dev Biol Stand (1986) 1.80

Low measles incidence: association with enforcement of school immunization laws. Am J Public Health (1981) 1.79

Current features of measles in the United States: feasibility of measles elimination. Epidemiol Rev (1980) 1.76

Age-specific risks of varicella complications. Pediatrics (1981) 1.76

Costs of care. Am J Public Health (1982) 1.74

The resurgence of measles in the United States, 1989-1990. Annu Rev Med (1992) 1.72

Costs of immunization registries: experiences from the All Kids Count II Projects. Am J Prev Med (2000) 1.72

The case for global eradication of poliomyelitis. Bull World Health Organ (1987) 1.72

Health impact of measles vaccination in the United States. Pediatrics (1985) 1.71

Current status of mumps and mumps vaccine in the United States. Pediatrics (1978) 1.71

Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures. Am J Public Health (1987) 1.70

Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70

Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet (2000) 1.68

Outbreak of paralytic poliomyelitis, Taiwan. Lancet (1984) 1.68

Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet (1990) 1.67

Immunogenicity and safety of measles vaccine in ill African children. Int J Epidemiol (1988) 1.67

Gastroenteritis due to rotavirus in an isolated Pacific island group: an epidemic of 3,439 cases. J Infect Dis (1980) 1.65

Health services in Shanghai County: introduction to Shanghai County. Am J Public Health (1982) 1.63

Herpes simplex virus microneutralization: a simplification of the test. J Infect Dis (1975) 1.63

Epidemiology of pertussis, Atlanta, 1977. J Pediatr (1981) 1.62

The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry (2004) 1.61

Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs. JAMA (1984) 1.59

Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine. Pediatrics (1989) 1.57

Epidemic measles in a highly vaccinated population. N Engl J Med (1977) 1.54

Human infection with monkeypox virus: laboratory investigation of six cases in West Africa. Bull World Health Organ (1972) 1.53

Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53

An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol (1989) 1.53

Elimination of indigenous measles from the United States. Rev Infect Dis (1983) 1.50

Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Equine Vet J (2008) 1.50

Causes of low preschool immunization coverage in the United States. Annu Rev Public Health (1992) 1.45

Resurgence of measles in New York. Am J Public Health (1972) 1.43

The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak. Am J Epidemiol (1995) 1.43

Global progress in infectious disease control. Vaccine (1998) 1.42

The Russian flu. Its history and implications for this year's influenza season. JAMA (1978) 1.41

A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy. Public Health Rep (1992) 1.41

Varicella: complications and costs. Pediatrics (1986) 1.41